Skip to main content
SpringerLink
Log in

The role of glutamate and GABA receptors in the anticonvulsive effects of levetiracetam and a 4-phenylpirrolidone derivative (GIZh-290) in rats

  • Experimental Articles
  • Published:
Neurochemical Journal Aims and scope Submit manuscript

Abstract

The method of radioligand binding ex vivo has been used to evaluate the involvement of the ionotropic and metabotropic glutamate and GABA receptors in the mechanism of anticonvulsant action of levetiracetam and the original compound GIZh-290 (2-oxo-4-phenylpyrrolidin-1-yl) acetic acid) in the rat brain. We found that at the peak of lithium-pilocarpine seizures, the Bmax value (the density of specific binding sites) decreases for [3H]-SR 95531, [3H](–)baclofen, [3Н](+)MK-801, and [3H]LY 354740 by 30–50% from the control level. The pre-treatment with levetiracetam (600 mg/kg) 40 minutes before pilocarpine kept the number of GABA- and NMDA-type receptors at the control level without affecting the metabotropic receptors. The administration of GIZh-290 (5.0 mg/kg), in contrast, maintained the density of GABAA receptors at the control level, while the density of other types of receptors remained decreased at the peak of seizures. Thus, the anticonvulsant effect of levetiracetam and GIZh-290 has different mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lason, W., Chlebicka, M., and Rejdak, K., Pharmacological Reports, 2013, vol. 65, pp. 787–801.

    Article  CAS  PubMed  Google Scholar 

  2. Meldrum, B.S. and Rogawski, M.A., Neurotherapeutics, 2007, vol. 4, no. 1, pp. 18–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Porter, R.J., Dhir, A., Macdonald, R.L., and Rogawski, M.A., Handb. Clin. Neurol, 2012, vol. 108, pp. 663–681.

    Article  PubMed  Google Scholar 

  4. Snead, O.C. III, Pharmacol. Biochem. Behav., 1996, vol. 53, pp. 73–79.

    Article  CAS  PubMed  Google Scholar 

  5. Alexander, G.M. and Godwin, D.W., Epilepsy Res., 2012, vol. 71, pp. 1–22.

    Article  Google Scholar 

  6. Kovalev, I.G., Voronina, T.A., Litvinova, S.A., Zhmurenko, L.A., and Mokrov, G.V., Eksperim. Klin. Farmakol., 2017, vol. 80, no. 6, pp. 13–18.

    Google Scholar 

  7. Leite, J.P., Garcia-Cairasco, N., and Cavalheiro, E.A., Epilepsy Res., 2002, vol. 50, nos. 1–2, pp. 93–103.

    Article  CAS  PubMed  Google Scholar 

  8. Jope, R.S., Morrisett, R.A., and Snead, O.C., Exp. Neurol., 1986, vol. 91, pp. 471–480.

    Article  CAS  PubMed  Google Scholar 

  9. Klitgaard, H., Matagne, A., Grimee, R., Vanneste-Goemaere, J., and Margineanu, D., Seizure, 2003, vol. 12, pp. 92–100.

    Article  PubMed  Google Scholar 

  10. Ito, Y., Lim, D.K., Hayase, Y., Murakoshi, Y., and Ho, I.K., Neurochem Res., 1992, vol. 17, no. 4, pp. 307–313.

    Article  CAS  PubMed  Google Scholar 

  11. Hawkinson, J., Acosta-Burruel, M., Kimbrough, C.L., Goodnough, D.B., and Wood, P.L., Eur. J. Pharmacol., 1996, vol. 304, nos. 1–3, pp. 141–146.

    Article  CAS  PubMed  Google Scholar 

  12. Bowery, N.G., Hill, D.R., and Hudson, A.L., Neuropharmacology, 1985, vol. 24, no. 3, pp. 207–210.

    Article  CAS  PubMed  Google Scholar 

  13. Szekely, A.M., Barbaccia, M.L., and Costa, E., J. Pharmacol. Exp. Ther., 1987, vol. 243, no. 1, pp. 155–159.

    CAS  PubMed  Google Scholar 

  14. Zhou, L.M., Gu, Z.Q., Costa, A.M., Yamada, K.A., and Manssone, P.E., J. Pharm. Exp. Ter, 1997, vol. 280, no. 1, pp. 422–427.

    CAS  Google Scholar 

  15. LaPage, K.T., Ishmael, J.E., Low, C.W., Traynelis, S.F., and Murray, T.F., Neuropharmacology, 2005, vol. 49, pp. 1–16.

    Article  Google Scholar 

  16. Schaffhauser, H., Richards, J.G., Cartmell, J., Chaboz, S., Kemp, J.A., Klingelschmidt, A., Messer, J., Stadler, H., Woltering, T., and Mutel, V., Molecular Pharmacology, 1998, vol. 53, pp. 228–233.

    Article  CAS  PubMed  Google Scholar 

  17. Noyer, M., Gillard, M., Matagne, A., Henichart, J.-P., and Wulfert, E., Eur. J. Pharmacol., 1995, vol. 286, pp. 137–146.

    Article  CAS  PubMed  Google Scholar 

  18. Lynch, B.A., Lambeng, L., Nocka, K., Kensel-Hammes, P., Bajjalieh, S.M., Matagne, A., and Fuks, B., Proc. Natl. Acad. Sci. U.S.A., 2004, vol. 101, pp. 9861–9866.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Rogawski, M.A. and Basil, C.W., Curr. Neurol. Neurosci. Rep., vol. 8, no. 4, pp. 345–352.

  20. Hamilton, S.E., Loose, M.D., Qi, M., Levey, A.I., Hille, B., Mcknight, G.S., Idzerda, R., and Nathanson, N.M., Proc. Natl. Acad. Sci. U.S.A., 1997, vol. 94, pp. 13311–13316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Clifford, D.B., Olney, J.W., Maniotis, A., Collins, R.C., and Zorumski, C.F., Neuroscience, 1987, vol. 23, pp. 953–968.

    Article  CAS  PubMed  Google Scholar 

  22. Priel, M.R. and Albuquerque, E.X., Epilepsia, 2002, vol. 43, no. 5, pp. 40–46.

    Article  CAS  PubMed  Google Scholar 

  23. Nagao, T., Alonso, A., and Avoli, M., Neuroscience, 1996, vol. 72, pp. 399–408.

    Article  CAS  PubMed  Google Scholar 

  24. Smolders, I., Khan, G.M., Lindekens, H., Prikken, S., Marvin, C.A., Manil, J., Ebinger, G., and Michotte, Y., J. Pharmacol. Exp. Ther., 1997, vol. 283, pp. 1239–1248.

    CAS  PubMed  Google Scholar 

  25. Waszczak, B.L., Kyu, LeeE., and Walters, J.R., J. Pharmacol. Exp. Ther., 1986, vol. 239, pp. 606–611.

    CAS  PubMed  Google Scholar 

  26. Carter, D.S., Deshpande, L.S., Rafiq, A., Sombati, S., and DeLorenzo, R.J., Seizure, 2010, vol. 20, pp. 218–224.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bayer, T.A., Wiestler, O.D., and Wolf, H.K., Acta Neuropathol., 1995, vol. 89, pp. 446–450.

    Article  CAS  PubMed  Google Scholar 

  28. Ghasemi, M. and Schachter, S.C., Epilepsy & Behavior, 2011, vol. 22, pp. 617–640.

    Article  Google Scholar 

  29. Ohishi, H., Shigemoto, R., Nakanishi, S., and Mizuno, N., Neuroscience, 1993, vol. 53, pp. 1009–1018.

    Article  CAS  PubMed  Google Scholar 

  30. Petralia, R.S., Wang, Y.X., Niedzielski, A.S., and Wenthold, R.J., Neuroscience, 1996, vol. 71, pp. 949–976.

    Article  CAS  PubMed  Google Scholar 

  31. Shigemoto, R., Kinoshita, A., Wada, E., Nomura, S., Ohishi, H., Takada, M., Flor, P.J., Neki, A., Abe, T., Nakanishi, Sh., and Mizuno, N., J. Neurosci., 1997, vol. 17, pp. 7503–7522.

    CAS  PubMed  Google Scholar 

  32. Cavus, I., Kasoff, W.S., Cassaday, M.P., Jacob, R., Gueorguieva, R., Sherwin, R.S., Krysta, J.H., Spence, D.D., and Abi-Saab, W.M., Ann. Neurol., 2005, vol. 57, pp. 226–235.

    Article  CAS  PubMed  Google Scholar 

  33. During, M.J. and Spencer, D.D., Lancet, 1993, vol. 341, pp. 1607–1610.

    Article  CAS  PubMed  Google Scholar 

  34. Tang, F.R., Chia, S.C., Chen, P.M., Gao, H., Lee, W.L., Yeo, T.S., Burgunder, J.M., Probst, A., Simf, M.K., and Ling, E.A., Epilepsy Res., 2004, vol. 59, pp. 167–180.

    Article  CAS  PubMed  Google Scholar 

  35. Ali, I., Boets, S., Janssens, P., Van Eetveldt, A., Amhaoul, H., Langlois, X., and Dedeurwaerdere, S., Epilepsy Res., 2016, vol. 127, pp. 55–59.

    Article  CAS  PubMed  Google Scholar 

  36. Loup, F., Wieser, H.G., Yonekawa, Y., Aguzzi, A., and Fritschy, J.-M., J. Neurosci., 2000, vol. 20, pp. 5401–5419.

    CAS  PubMed  Google Scholar 

  37. Loup, F., Picard, F., Andre, V.M., Kehrli, P., Yonekawa, Y., Wieser, H.-G., and Fritschy, J.-M., Brain, 2006, vol. 129, pp. 3277–3289.

    Article  PubMed  Google Scholar 

  38. Zhang, N., Wei, W., Mody, I., and Houser, C.R., J. Neurosci., 2007, vol. 27, pp. 7520–7531.

    Article  CAS  PubMed  Google Scholar 

  39. Kumar, K., Sharma, S., Kumar, P., and Deshmukh, R., Pharmacol. Biochem. Behav., 2013, vol. 110, pp. 174–184.

    Article  CAS  PubMed  Google Scholar 

  40. Inaba, Y., D’Antuono, M., Bertazzoni, G., Biagini, G., and Avoli, M., Neurosignals, 2009, vol. 17, no. 2, pp. 121–131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zakusov Research Institute of Pharmacology, Moscow, Russia

    I. G. Kovalev, E. V. Vasil’eva, E. A. Kondrakhin, T. A. Voronina & G. I. Kovalev

  2. Baltiiskaya 8, Moscow, 125315, Russia

    G. I. Kovalev

Authors
  1. I. G. Kovalev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. V. Vasil’eva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. A. Kondrakhin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. A. Voronina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. I. Kovalev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. I. Kovalev.

Additional information

Original Russian Text © I.G. Kovalev, E.V. Vasil’eva, E.A. Kondrakhin, T.A. Voronina, G.I. Kovalev, 2017, published in Neirokhimiya, 2017, Vol. 34, No. 4, pp. 335–343.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kovalev, I.G., Vasil’eva, E.V., Kondrakhin, E.A. et al. The role of glutamate and GABA receptors in the anticonvulsive effects of levetiracetam and a 4-phenylpirrolidone derivative (GIZh-290) in rats. Neurochem. J. 11, 332–339 (2017). https://doi.org/10.1134/S1819712417040055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1819712417040055

Keywords

Search

Navigation